Methods for producing aflibercept in chemically defined media having reduced aflibercept variants | Patent Number 11104715

US 11104715 B2
Application Number16996030
Publication NumberUS 20210206832 A1
Pendency1 year, 13 days
Filled DateAug 18, 2020
Priority DateDec 6, 2019
Publication DateJul 8, 2021
Expiration DateDec 5, 2039
Inventor/ApplicantsShawn Lawrence
Ning Li
Meghan Casey
Amy Johnson
Jaimie Mastrogiacomo
Shunhai Wang
ExaminesRAMIREZ, DELIA M
Art Unit1652
Technology Center1600
Assignments
Regeneron Pharmaceuticals
Current
Regeneron Pharmaceuticals
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.